Use of Santyl in Diabetic Foot Ulcers

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.

Also called NCT02581488

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 102 participants (enrolled count) (from the registry)
Sponsor
Smith & Nephew, Inc. (from the registry)
Registry
  • NCT NCT02581488
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02581488. Randomized; no masking; primary purpose treatment. Start 2015-10 (actual); primary completion 2017-01-12 (actual). Results posted on 2018-08-01.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Use of Santyl in Diabetic Foot Ulcers
Condition
Diabetic Foot
Condition
Foot Ulcer, Diabetic
Intervention (Biological)
Santyl
Intervention (Other)
Product containing silver
Lead sponsor
Smith & Nephew, Inc. (class: industry)

Record details

Record id
cardio:ct-nct02581488
Content hash
90119d4027cb22a6799f43defdc443c9ac3eb45e0db78aae2630ff7ecb6e9efd